With the best-selling medication in the world, tirzepatide, and a record-setting $1 trillion valuation to go with it, Eli ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

The Biotechnology Innovation Organization’s CEO John Crowley isn’t shying away from the tough tasks. With only a little more than three months at the helm of the world’s largest biotech advocacy group ...

Unexpected delays, infighting and a staffing crisis are fueling investors’ unease.

Moleculin Biotech (MBRX) announced it has entered into a research and material transfer agreement with CIC biomaGUNE, a non-profit research ...

The Biden administration will soon make a decision with huge implications for California’s biotech industry — and the patients who depend on it to produce cures for life-threatening diseases. The ...

The U.S. and U.K. reached a new pharmaceutical pricing agreement to boost innovation, raise U.K. payments for new medicines ...

Biotechnology today demands not just domain knowledge but also creativity, ethics, and transdisciplinary thinking, as ...

Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...